Value proposition

Team of specialized thinkers and executors in health and science innovation. Global Alliance with Omnicom PR Group

LaVoieHealthScience provides strategic communications programs that integrate public and investor relations, marketing and communications to engage target stakeholders to create behavioral change. Our focus is on building value for health science innovations. Through our alliance with Omnicom Public Relations Group, we bring high-touch service with the global scale of 2,000 health expert consults across 100 countries.

We help our clients create awareness, gain recognition and optimal value for their initiatives, technologies, products and businesses. Our expert team of investor relations and public relations professionals design and execute communications programs that allow a client, product or initiative to reach its goals. We deliver a proven track record of designing and executing creative programs that effectively position and engage key stakeholders, with measurable return on investment.

Specializing in public health & wellness, biotech & pharma, medical technology and device markets, LaVoieHealthScience has a keen focus on strategic communications for the C-suite. We create and execute investor and public relations programs with a targeted market focus and/or a global point of view.

LaVoieHealthScience bring 18 years of industry-tested counsel, over 300 proven strategies for our clients, and differentiated communications programs to engage key stakeholders.

LaVoieHealthScience is honored to have won over 30 awards across multiple communications disciplines over the last nine years and is rated among the Top 30 Independent Healthcare PR Agencies and one of Inc. 5000’s Fastest Growing Private Companies.

life sciences, pharmaceuticals, biotech, medical device, communications programs, emerging growth, clinical, healthcare, healthcare IT, diagnostics, medical technology, public relations, communications, investor relations, marketng communications, social media, roadshows, and investor relations